Teva Pharmaceutical TEVA Climbs 232 as Stock Nears Key Resistance at 3709 The Energy Sector DealMaking Dynamics Gain Traction ARES Q1 2026 Earnings EPS Misses Estimates but Stock Rallies on Resilient Business Trends Futu Holdings Downgraded by Goldman Sachs Amid Regulatory Pressures in China RFL Q1 2025 Earnings Wider Loss Stems From Continued Clinical Investment OZKAP Q1 2026 Earnings Marginal EPS Miss Amid Stable Performance ENVA Q1 2026 Earnings EPS Beats Estimates by 335 Stock Edges Lower HUBB Q1 2026 Earnings EPS Misses Estimates by a Slim Margin Shares Edge Lower MPLX Q1 2026 Earnings Adjusted EPS Falls Short of Estimates Revenue Data Not Disclosed AVNW Q1 2026 Earnings EPS Misses Estimates Sharply Amid Weak Revenue Quarter Kyntra Bio Inc Q1 2026 Earnings EPS Miss Amid Ongoing PreRevenue Development Phase LPRO Earnings Overview 20260529 FCNCN Q1 2026 Earnings Preferred EPS Surges Past Estimates Despite Stock Decline